Market closed
OptimizeRx/$OPRX
OptimizeRx shares are trading higher after the company reported Q1 earnings and revenue that exceeded estimates.
5 hours ago·Lightyear AI
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About OptimizeRx
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its product offerings are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.
Ticker
$OPRX
Sector
Trading on
Industry
Health Care Technology
Headquarters
Employees
129
ISIN
US68401U2042
Website
OptimizeRx Metrics
BasicAdvanced
$187M
-
-$0.84
1.28
-
Price and volume
Market cap
$187M
Beta
1.28
52-week high
$14.13
52-week low
$3.78
Average daily volume
258K
Financial strength
Current ratio
2.818
Quick ratio
2.692
Long term debt to equity
25.252
Total debt to equity
28.21
Interest coverage (TTM)
-0.56%
Management effectiveness
Return on assets (TTM)
-1.20%
Return on equity (TTM)
-12.91%
Valuation
Price to revenue (TTM)
1.968
Price to book
1.61
Price to tangible book (TTM)
208.9
Price to free cash flow (TTM)
29.693
Growth
Revenue change (TTM)
20.66%
Earnings per share change (TTM)
-19.78%
3-year revenue growth (CAGR)
13.94%
3-year earnings per share growth (CAGR)
75.30%
What the Analysts think about OptimizeRx
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for OptimizeRx stock.
OptimizeRx Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
OptimizeRx Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
OptimizeRx News
AllArticlesVideos
OptimizeRx Corporation (OPRX) Q1 2025 Earnings Call Transcript
Seeking Alpha·3 days ago
OptimizeRx Reports First Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance
GlobeNewsWire·3 days ago
OptimizeRx Releases 2025 Environmental, Social, and Governance (ESG) Report
GlobeNewsWire·2 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for OptimizeRx stock?
OptimizeRx (OPRX) has a market cap of $187M as of May 16, 2025.
What is the P/E ratio for OptimizeRx stock?
The price to earnings (P/E) ratio for OptimizeRx (OPRX) stock is 0 as of May 16, 2025.
Does OptimizeRx stock pay dividends?
No, OptimizeRx (OPRX) stock does not pay dividends to its shareholders as of May 16, 2025.
When is the next OptimizeRx dividend payment date?
OptimizeRx (OPRX) stock does not pay dividends to its shareholders.
What is the beta indicator for OptimizeRx?
OptimizeRx (OPRX) has a beta rating of 1.28. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.